News, views and contacts from the global Pharmaceutical industry
 

News Archive

Archive of industry news from the global pharmaceutical industry

News By Date

October 2014

Top

Pharmacyclics’ Imbruvica receives European approval for two blood cancers
20 October 2014 US-based Pharmacyclics has received marketing approval from the European Commission (EC) for its Imbruvica (ibrutinib) to treat adult patients with relapsed or refractory mantle cell lymphoma...

Sanofi Pasteur and Immune Design to develop vaccine for herpes simplex virus
20 October 2014 Vaccines division Sanofi Pasteur has partnered with clinical-stage immunotherapy company Immune Design to develop herpes simplex virus (HSV) immune therapy....

AstraZeneca and University of Cambridge partner for research on neurodegenerative diseases
17 October 2014 AstraZeneca and subsidiary MedImmune have entered into four new collaborations with the University of Cambridge, expanding on their existing partnership....

Ranbaxy to pay $40m to settle overcharging Texas Medicaid programme litigation
17 October 2014 India-based drug maker Ranbaxy Laboratories has agreed to pay $39.75m to settle litigation about its participation in Texas Medicaid, a US health care programme for people with low incomes....

ViiV Healthcare’s HIV drug Triumeq obtains Canadian approval
16 October 2014 ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK), Pfizer and Shionogi, has obtained approval in Canada, for its Triumeq (dolutegravir) 50mg, abacavir 600mg, and lamivudine 300mg) to...

Genentech's IPF-treating drug Esbriet receives FDA approval
16 October 2014 Roche Group subsidiary Genentech has received approval from US Food and Drug Administration (FDA) for Esbriet (pirfenidone) drug to treat patients with idiopathic pulmonary fibrosis...

WHO warns of 10,000 new weekly Ebola cases
15 October 2014 The World Health Organisation (WHO) has warned West Africa may face up to 10,000 new Ebola cases per week within two months, due to the increasing number of...

Helsinn’s Akynzeo obtains FDA approval to treat chemotherapy-induced nausea and vomiting
15 October 2014 Switzerland-based Helsinn Healthcare has obtained US Food and Drug Administration approval for its fixed combination capsule Akynzeo to treat patients with chemotherapy-induced nausea and...

Hikma to market Eisai’s epilepsy treatment Fycompa in Middle East
14 October 2014 UK-based Hikma Pharmaceuticals has partnered with Eisai to distribute first-class epilepsy treatment Fycompa (perampanel) in the Middle East....

Gilead’s Harvoni receives FDA approval for hepatitis C genotype 1 infection
14 October 2014 Gilead Sciences has received approval from US Food and Drug Administration for Harvoni (ledipasvir 90mg/sofosbuvir 400mg), a once-daily single tablet regimen to treat chronic hepatitis C genotype...

NPPA fines Novartis India for over pricing painkiller Voveran
13 October 2014 India's National Pharmaceutical Pricing Authority (NPPA) has reportedly fined Swiss drug maker Novartis' subsidiary in the country for Rs3bn ($48.9m), for over pricing its painkiller medicine...

Takeda UK’s Adcetris receives SMC approval to treat relapsed or refractory CD30+ HL
13 October 2014 Takeda UK has received approval from the Scottish Medicines Consortium (SMC) for its Adcetris (brentuximab vedotin) for restricted use within NHS Scotland, in order to treat adult patients...

Cipla Medpro to market Teva’s pharmaceutical products in South Africa
10 October 2014 Cipla Medpro subsidiary Medpro Pharmaceutica has entered into an agreement with Teva...

GSK to acquire 25% stake in Aspen Japan
10 October 2014 British drug maker GlaxoSmithKline (GSK) has signed an agreement with Aspen Global (AGI) to acquire interest in its newly established subsidiary Aspen...

Boehringer brings Striverdi Respimat to market for COPD treatment in US
09 October 2014 Boehringer Ingelheim Pharmaceuticals has introduced Striverdi Respimat (olodaterol) inhalation spray 5µg in the US market....

Nabriva’s lefamulin receives FDA fast-track status to treat CABP and ABSSSI
09 October 2014 Austria-based Nabriva Therapeutics has received qualified infectious disease product (QIDP) and fast-track status designation from the US Food and Drug Administration for its lefamulin (BC 3781)....

EMD Serono, ICR and Wellcome Trust partner develop anti-cancer drugs
08 October 2014 Merck subsidiary EMD Serono, The Institute of Cancer Research (ICR) and the Wellcome Trust have entered into a co-development and licence agreement for new drug candidates to treat different...

ThromboGenics’ Jetrea receives Australia’s TGA approval to treat VMT
08 October 2014 Belgium-based ThromboGenics has received approval from the Australia’s Therapeutic Goods Administration (TGA), for its Jetrea (ocriplasmin) to treat adults with vitreomacular traction...

Novartis and BMS enter clinical collaboration to assess lung cancer treatments
07 October 2014 Swiss drug maker Novartis has partnered with US-based Bristol-Myers Squibb (BMS) to assess the safety, tolerability and preliminary efficacy of its three molecularly targeted compounds...

UK’s Medical Research Council grants fund for three new research programmes
07 October 2014 The UK Medical Research Council (MRC) has granted a fund of £6m for three new research programmes as part of a £60m...

Grupo Juste to supply D&A Pharma’s Alcover in Spain and Central America
06 October 2014 France-based D&A Pharma has entered into an exclusive supply, licensing and distribution agreement with Grupo Juste for Alcover, sodium oxybate, a treatment for alcohol...


cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1243308781_ap1243308781_1857678299_874850511